Belvedere Trading LLC Annexon, Inc. Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024
BUY
$4.03 - $7.81 $66,277 - $128,443
16,446 New
16,446 $117,000
Q2 2023

Aug 08, 2023
BUY
$2.1 - $6.37 $19,683 - $59,706
9,373 New
9,373 $32,000
Q4 2022

Feb 14, 2023
BUY
$4.56 - $6.61 $37,852 - $54,869
8,301 New
8,301 $42,000
Q2 2022

Jul 21, 2022
BUY
$2.11 - $4.06 $101,716 - $195,720
48,207 New
48,207 $248,000

Others Institutions Holding ANNX

# of Institutions
158
Shares Held
102M
Call Options Held
3.61M
Put Options Held
1.08M
View Full List

About Annexon, Inc.

ANNX Quotes by TradingView
  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $312M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email